This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1980;10(3):617-55.

doi: 10.1016/0163-7258(80)90031-5.

Clostridium perfringens toxins (type A, B, C, D, E)

PMID: 6255496
DOI: 10.1016/0163-7258(80)90031-5

Review

Clostridium perfringens toxins (type A, B, C, D, E)

J L McDonel. Pharmacol Ther. 1980.

. 1980;10(3):617-55.

doi: 10.1016/0163-7258(80)90031-5.

Author

PMID: 6255496
DOI: 10.1016/0163-7258(80)90031-5

No abstract available

PubMed Disclaimer

Similar articles

Cross-complementation of Clostridium perfringens PLC and Clostridium septicum alpha-toxin mutants reveals PLC is sufficient to mediate gas gangrene.
Kennedy CL, Lyras D, Cheung JK, Hiscox TJ, Emmins JJ, Rood JI. Kennedy CL, et al. Microbes Infect. 2009 Mar;11(3):413-8. doi: 10.1016/j.micinf.2009.01.002. Epub 2009 Jan 20. Microbes Infect. 2009. PMID: 19284973
[Characteristics of alpha-toxin of Clostridium perfringens and its role in the pathogenesis of gas gangrene (author's transl)].
Murata R, Ohsaka A. Murata R, et al. Nihon Saikingaku Zasshi. 1977 Sep;32(5):671-89. Nihon Saikingaku Zasshi. 1977. PMID: 199761 Japanese. No abstract available.
Pathogenesis of Clostridium perfringens infection: mechanisms and mediators of shock.
Stevens DL, Bryant AE. Stevens DL, et al. Clin Infect Dis. 1997 Sep;25 Suppl 2:S160-4. doi: 10.1086/516249. Clin Infect Dis. 1997. PMID: 9310664 No abstract available.
Vaccines against Clostridium perfringens alpha-toxin.
Nagahama M. Nagahama M. Curr Pharm Biotechnol. 2013;14(10):913-7. doi: 10.2174/1389201014666131226124348. Curr Pharm Biotechnol. 2013. PMID: 24372250 Review.
Opening of the active site of Clostridium perfringens alpha-toxin may be triggered by membrane binding.
Titball RW, Naylor CE, Miller J, Moss DS, Basak AK. Titball RW, et al. Int J Med Microbiol. 2000 Oct;290(4-5):357-61. doi: 10.1016/s1438-4221(00)80040-5. Int J Med Microbiol. 2000. PMID: 11111911 Review.

See all similar articles

Cited by

Protection against avian necrotic enteritis after immunisation with NetB genetic or formaldehyde toxoids.
Fernandes da Costa SP, Mot D, Bokori-Brown M, Savva CG, Basak AK, Van Immerseel F, Titball RW. Fernandes da Costa SP, et al. Vaccine. 2013 Aug 20;31(37):4003-8. doi: 10.1016/j.vaccine.2013.05.063. Epub 2013 May 29. Vaccine. 2013. PMID: 23727000 Free PMC article.
Clostridium perfringens Type C Enterotoxemia.
Niilo L. Niilo L. Can Vet J. 1988 Aug;29(8):658-64. Can Vet J. 1988. PMID: 17423103 Free PMC article.
Real-time PCR assay for Clostridium perfringens in broiler chickens in a challenge model of necrotic enteritis.
Wu SB, Rodgers N, Choct M. Wu SB, et al. Appl Environ Microbiol. 2011 Feb;77(3):1135-9. doi: 10.1128/AEM.01803-10. Epub 2010 Dec 10. Appl Environ Microbiol. 2011. PMID: 21148703 Free PMC article.
Structural basis of Clostridium perfringens toxin complex formation.
Adams JJ, Gregg K, Bayer EA, Boraston AB, Smith SP. Adams JJ, et al. Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12194-9. doi: 10.1073/pnas.0803154105. Epub 2008 Aug 20. Proc Natl Acad Sci U S A. 2008. PMID: 18716000 Free PMC article.
Sporicidal performance induced by photocatalytic production of organic peroxide under visible light irradiation.
Yamaguchi Y, Shimodo T, Chikamori N, Usuki S, Kanai Y, Endo T, Katsumata KI, Terashima C, Ikekita M, Fujishima A, Suzuki T, Sakai H, Nakata K. Yamaguchi Y, et al. Sci Rep. 2016 Sep 26;6:33715. doi: 10.1038/srep33715. Sci Rep. 2016. PMID: 27666195 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

AI 14161-02/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database